Back to Search
Start Over
Management and Outcomes for Primary Mediastinal B-Cell Lymphoma Patients with Partial Metabolic Response
- Source :
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p988-988, 1p
- Publication Year :
- 2023
-
Abstract
- Background:The optimal management of patients with primary mediastinal B-cell lymphoma (PMBCL) who experience a partial metabolic response (PMR) on FDG-PET after initial systemic therapy is unclear. This study aimed to investigate different management strategies and outcomes for PMBCL patients who achieved PMR following primary systemic therapy, utilizing a single-center retrospective design.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 142
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs64699807
- Full Text :
- https://doi.org/10.1182/blood-2023-190983